| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/03/2007 | CN1293058C O-cyclopropyl-carboxanilides and their use as fungicides |
| 01/03/2007 | CN1292749C Novel use of 2-[5-(40fluorophenyl)3-pyridylmethylaminomethyl] |
| 01/02/2007 | US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions |
| 01/02/2007 | US7157580 Aminopyrimidine and aminopyridine anti-inflammation agents |
| 01/02/2007 | US7157489 HIV protease inhibitors |
| 01/02/2007 | US7157488 N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine; treating schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders |
| 01/02/2007 | US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
| 01/02/2007 | US7157474 Mixing at least one nonaqueous, pharmaceutically acceptable solvent and a taxane compound |
| 01/02/2007 | US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 01/02/2007 | US7157467 Therapeutic use |
| 01/02/2007 | US7157466 Quinazoline ditosylate salt compounds |
| 01/02/2007 | US7157464 Substituted piperazines |
| 01/02/2007 | US7157455 4-Aminopyrimidine-5-one derivatives |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157441 Administering an anti-virally effective amount of 1', 2' or 3'-modified nucleoside for therapy of hepatitis C virus infection |
| 01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 01/02/2007 | US7157124 used for a molded article having an optical anisotropy, a liquid crystal display element and the like; polyester, polyether, polesterether copolymers |
| 01/02/2007 | CA2153419C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 12/28/2006 | WO2006138218A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 12/28/2006 | WO2006137797A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 12/28/2006 | WO2006137796A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 12/28/2006 | WO2006137793A1 New 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 12/28/2006 | WO2006137792A1 New 2-azetidinone derivatives useful in the treatment of hyperlipidaemic conditions |
| 12/28/2006 | WO2006137773A1 Process for the isolation of 4-(oxiranylmethoxy)-benzonitriles |
| 12/28/2006 | WO2006137485A1 Novel nitrogenated heterocyclic compound and salt thereof |
| 12/28/2006 | WO2006137447A1 Stable crystal of protected pseudouridine |
| 12/28/2006 | WO2006137421A1 Agent for topical administration |
| 12/28/2006 | WO2006137389A1 Novel insecticidal/miticidal agent |
| 12/28/2006 | WO2006137314A1 Radial brush |
| 12/28/2006 | WO2006136442A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 12/28/2006 | WO2006136302A1 Solid pharmaceutical preparation containing (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman |
| 12/28/2006 | WO2006135973A1 Small molecule glycosaminoglycan mimetics |
| 12/28/2006 | WO2006098918B1 Substituted gamma lactams as therapeutic agents |
| 12/28/2006 | WO2006060381A3 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| 12/28/2006 | WO2006055463A3 2-amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 12/28/2006 | WO2005087752A8 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 12/28/2006 | US20060293528 Method of purifying dianhydrides |
| 12/28/2006 | US20060293527 Analogs of epothilone |
| 12/28/2006 | US20060293380 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 12/28/2006 | US20060293376 Benzopyran derivatives substituted with a benzimidazole derviative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 12/28/2006 | US20060293371 Prodrug and process for producing the same |
| 12/28/2006 | US20060293361 Compounds |
| 12/28/2006 | US20060293360 4-(2-Phenyloxyphenyl)-piperidine or-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 12/28/2006 | US20060293354 Pyrimidine derivatives and their use as CB2 modulators |
| 12/28/2006 | US20060293353 Matrix metalloproteinase inhibitors |
| 12/28/2006 | US20060293349 5-Chloro-4-alkyl-3,4-dihydro-quinazolin-2-ylamine derivatives |
| 12/28/2006 | US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase |
| 12/28/2006 | US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/28/2006 | US20060293321 2-Heterosubstituted 3-aryl-4H-1-benzopyran-4-ones as novel therapeutics in breast cancer |
| 12/28/2006 | US20060293313 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; shows high affinity for both the dopamine D2 receptor and the serotonin reuptake site, useful for treating central nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia |
| 12/28/2006 | US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 12/28/2006 | US20060293297 Cyanofluoropyrrolidine derviative |
| 12/28/2006 | US20060292588 Assay systems, kits and methods for detecting microorganisms |
| 12/28/2006 | CA2612738A1 Solid pharmaceutical composition comprising (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman |
| 12/28/2006 | CA2612491A1 Tricyclic opioid modulators |
| 12/28/2006 | CA2612325A1 Chemokine receptor binding compounds |
| 12/28/2006 | CA2612105A1 Chemokine receptor binding compounds |
| 12/28/2006 | CA2610742A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 12/28/2006 | CA2610102A1 New 2-azetidinone derivatives useful in the treatment of hyperlipidaemic conditions |
| 12/28/2006 | CA2610036A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 12/28/2006 | CA2609993A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 12/28/2006 | CA2609990A1 New 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 12/27/2006 | EP1736473A2 Oxetane compounds containing maleimide functionality |
| 12/27/2006 | EP1736471A1 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines |
| 12/27/2006 | EP1736466A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 12/27/2006 | EP1736158A2 Use of 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiologically acceptable salts |
| 12/27/2006 | EP1735307A1 Inhibitors of iap |
| 12/27/2006 | EP1735302A1 4-amino-piperidine derivatives as monoamine uptake inhibitors |
| 12/27/2006 | EP1735301A1 Pyridine derivatives as cannabinoid receptor modulators |
| 12/27/2006 | EP1735300A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 12/27/2006 | EP1735293A2 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 12/27/2006 | EP1735286A1 Tetrahydro-indazole cannabinoid modulators |
| 12/27/2006 | EP1735285A2 Pyrazole-amine compounds for the treatment of neurodegenerative disorders |
| 12/27/2006 | EP1735282A1 Pyrazole compounds and uses related thereto |
| 12/27/2006 | EP1735278A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 12/27/2006 | EP1734948A1 Tri-substitued 2-benzhydryl-5-benzlamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives |
| 12/27/2006 | EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 12/27/2006 | EP1471786B1 Microbiocidal n-phenyl-n- 4-(4-pyridyl)-2-pyrimidin-2-yl|-amine derivatives |
| 12/27/2006 | EP1436267B1 Lactam derivatives as antagonists for human 11cby receptors |
| 12/27/2006 | EP1406876B1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 12/27/2006 | EP1379515B1 Lipid lowering biphenylcarboxamides |
| 12/27/2006 | EP1299374B1 Novel non-psychotropic cannabinoids |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | CN1886421A Hemiasterlin derivatives and uses thereof |
| 12/27/2006 | CN1886402A pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists |
| 12/27/2006 | CN1886401A Benzoyl amino pyridil carboxylic acid derivatives as gluokinase activators |
| 12/27/2006 | CN1886400A 9, 10-alpha, alpha-OH-taxane analogs and methods for production thereof |
| 12/27/2006 | CN1886399A 喹唑啉衍生物 Quinazoline derivatives |
| 12/27/2006 | CN1886397A 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3) |
| 12/27/2006 | CN1886392A Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder |
| 12/27/2006 | CN1886391A Tetronic and tetramic acids as inhibitors of beta-secrease |
| 12/27/2006 | CN1886386A Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 12/27/2006 | CN1886382A Substituted dihydropyrimidinone preparation using polyaniline salt catalyst |
| 12/27/2006 | CN1886381A Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 12/27/2006 | CN1886379A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 12/27/2006 | CN1886378A 1,4-disubstituted isoquinilone derivatives as RAF-kinase inhibitors useful for the treatment of proliferative diseases |
| 12/27/2006 | CN1884280A Process for the preparation of piribedil |
| 12/27/2006 | CN1884266A Aromatic-cyclo and heterocyclo acylmethyl imidazole salts compound and method for preparing same |
| 12/27/2006 | CN1291983C Luminescent element material and luminescent element comprising the same |